{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:13:40Z","timestamp":1791314020111,"version":"4.3.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.neuropharm.2010.11.024","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T04:14:34Z","timestamp":1291781674000},"page":"642-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy"],"prefix":"10.1016","volume":"60","author":[{"given":"Maria Gabriela","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Estrada-Camarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"B\u00e9langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.11.024_bib1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/ENDO:21:1:97","article-title":"Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys","volume":"21","author":"Belanger","year":"2003","journal-title":"Endocrine"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/mds.10589","article-title":"Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys","volume":"18","author":"Belanger","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yfrne.2009.04.003","article-title":"Protective actions of ovarian hormones in the serotonin system of macaques","volume":"30","author":"Bethea","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.53.1.91","article-title":"Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study","volume":"53","author":"Blanchet","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2009.12.028","article-title":"Altered function of the serotonin 1A autoreceptor and the antidepressant response","volume":"65","author":"Blier","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib7","first-page":"37","article-title":"Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain","volume":"26","author":"Blier","year":"2001","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib8","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson\u2019s disease: a preliminary PET study with [11C]DASB","volume":"23","author":"Boileau","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0306-4530(98)00044-4","article-title":"Pregnancy, the postpartum, and steroid hormones: effects on cognition and mood","volume":"24","author":"Buckwalter","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuroscience.2004.05.031","article-title":"Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors","volume":"127","author":"Carrasco","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/jpn.0427","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1749-6632.1998.tb10229.x","article-title":"Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson\u2019s disease neocortex","volume":"861","author":"Chen","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00002512-200219060-00002","article-title":"Estrogen and Alzheimer\u2019s disease: the story so far","volume":"19","author":"Cholerton","year":"2002","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1176\/appi.ajp.160.8.1519","article-title":"Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report","volume":"160","author":"Cohen","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1468-1331.2006.01406.x","article-title":"Major and minor depression in Parkinson\u2019s disease: a neuropsychological investigation","volume":"13","author":"Costa","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0306-4522(97)00445-4","article-title":"Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex","volume":"83","author":"Cyr","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1139\/jpn.0202","article-title":"Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson\u2019s disease","volume":"27","author":"Cyr","year":"2002","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W","article-title":"5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response","volume":"15","author":"Cryan","year":"2000","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/13543784.14.4.435","article-title":"Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms","volume":"14","author":"Deecher","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00213-003-1707-4","article-title":"Interaction between estrogens and antidepressants in the forced swimming test in rats","volume":"173","author":"Estrada-Camarena","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.npp.1300821","article-title":"Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test","volume":"31","author":"Estrada-Camarena","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/FBP.0b013e32833db7e9","article-title":"Antidepressant effects of estrogens: a basic approximation","volume":"21","author":"Estrada-Camarena","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-008-1291-8","article-title":"Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test","volume":"201","author":"Estrada-Camarena","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neulet.2006.05.023","article-title":"Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A\/7 receptor agonist 8-OH-DPAT","volume":"404","author":"Faure","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2010.11.024_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0924-9338(02)80187-0","article-title":"Hormones and mental disorders-focus on estrogen-serotonin interactions","volume":"17","author":"Fink","year":"2002","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1098-2396(20010315)39:4<288::AID-SYN1011>3.0.CO;2-V","article-title":"Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys","volume":"39","author":"Frechilla","year":"2001","journal-title":"Synapse"},{"issue":"Suppl. 4","key":"10.1016\/j.neuropharm.2010.11.024_bib27","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_4.S13","article-title":"Highlights from the latest WHI publications and the latest North American Menopause Society position statement on use of menopausal hormone therapy","volume":"75","author":"Gass","year":"2008","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1347.007","article-title":"Clinical pharmacology and differential cognitive efficacy of estrogen preparations","volume":"1052","author":"Gleason","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00018-004-4385-z","article-title":"Neuroprotective effects of female sex steroids in humans: current controversies and future directions","volume":"62","author":"Gleason","year":"2005","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.109.162123","article-title":"Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors","volume":"333","author":"Gogos","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1258\/mi.2009.009021","article-title":"Depression and the menopause: why antidepressants are not enough?","volume":"15","author":"Graziottin","year":"2009","journal-title":"Menopause Int."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.parkreldis.2008.11.001","article-title":"Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys","volume":"15","author":"Gregoire","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","article-title":"The 5-HT7 receptor and disorders of the nervous system: an overview","volume":"206","author":"Hedlund","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","article-title":"Functional, molecular and pharmacological advances in 5-HT7 receptor research","volume":"25","author":"Hedlund","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12020-008-9087-5","article-title":"Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques","volume":"33","author":"Henderson","year":"2008","journal-title":"Endocrine"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib36","article-title":"5-HT(2A) receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA","author":"Huot","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib37","first-page":"497","article-title":"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson\u2019s disease, with emphasis on mice and nonhuman primates","volume":"54","author":"Jakowec","year":"2004","journal-title":"Comp. Med."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0317167100009665","article-title":"Depression in Parkinson\u2019s disease","volume":"37","author":"Jasinska-Myga","year":"2010","journal-title":"Can. J. Neurol. Sci."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2010.11.024_bib39","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/0303-8467(92)90033-Y","article-title":"Clinico-pathological correlations in Parkinson\u2019s disease","volume":"94","author":"Jellinger","year":"1992","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181f11c1d","article-title":"Regional patterns of brain tissue loss associated with depression in Parkinson disease","volume":"75","author":"Kostic","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib41","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1176\/appi.ajp.160.8.1522","article-title":"Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women","volume":"160","author":"Kugaya","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0169-328X(03)00049-4","article-title":"Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor","volume":"112","author":"Landry","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1139\/jpn.0517","article-title":"Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene","volume":"30","author":"Le Saux","year":"2005","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/syn.20722","article-title":"Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats","volume":"64","author":"Li","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00536.x","article-title":"Depression in Parkinson\u2019s disease \u2013 a review","volume":"113","author":"Lieberman","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0893-133X(01)00423-7","article-title":"Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys","volume":"27","author":"Lu","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib47","series-title":"Primate Brain Maps: Structure of the Macaque Brain","author":"Martin","year":"2000"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ana.410280111","article-title":"Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson\u2019s disease","volume":"28","author":"Mayberg","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/ajp.143.6.756","article-title":"Clinical and biochemical features of depression in Parkinson\u2019s disease","volume":"143","author":"Mayeux","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson\u2019s disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/rp.57.1.357","article-title":"Estrogen actions throughout the brain","volume":"57","author":"McEwen","year":"2002","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib52","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1210\/jcem.84.6.5761","article-title":"Clinical review 108: the molecular and neuroanatomical basis for estrogen effects in the central nervous system","volume":"84","author":"McEwen","year":"1999","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1073858405278330","article-title":"Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems","volume":"11","author":"Miller","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib54","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/jnr.21977","article-title":"Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys","volume":"87","author":"Morissette","year":"2009","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib55","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0015-0282(03)00973-7","article-title":"Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women","volume":"80","author":"Moses-Kolko","year":"2003","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib56","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of l-DOPA-induced dyskinesia","volume":"131","author":"Munoz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib57","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/wnf.0b013e318050c9f9","article-title":"Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: a crossover trial","volume":"30","author":"Nicoletti","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0169-328X(99)00274-0","article-title":"The flinders sensitive line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17beta-estradiol","volume":"74","author":"Osterlund","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09513599809012838","article-title":"The psychotherapeutic effects of estrogens","volume":"12","author":"Panay","year":"1998","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib60","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1210\/en.2007-0034","article-title":"Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors","volume":"148","author":"Papageorgiou","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0169-328X(97)00286-6","article-title":"Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques","volume":"53","author":"Pecins-Thompson","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(93)90995-Y","article-title":"Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study","volume":"606","author":"Radja","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0072-9752(07)83007-7","article-title":"Neurochemistry of Parkinson\u2019s disease","volume":"83","author":"Rao","year":"2007","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib65","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Rapp","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.12.003","article-title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants","volume":"65","author":"Richardson-Jones","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.165.3.333","article-title":"Depression in Parkinson\u2019s disease. A positron emission study","volume":"165","author":"Ring","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","article-title":"Increased risk of parkinsonism in women who underwent oophorectomy before menopause","volume":"70","author":"Rocca","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib69","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/gme.0b013e318174f155","article-title":"Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy","volume":"15","author":"Rocca","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib70","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(98)00126-9","article-title":"Frontostriatal deficits in unipolar major depression","volume":"47","author":"Rogers","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib72","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/j.1755-5949.2010.00163.x","article-title":"Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Sanchez","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib73","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.psyneuen.2008.05.006","article-title":"Estradiol-sertraline synergy in ovariectomized rats","volume":"33","author":"Sell","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000161058","article-title":"Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson\u2019s disease dementia","volume":"26","author":"Sharp","year":"2008","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2001-0016","article-title":"Estrogen and cognitive functioning in women","volume":"24","author":"Sherwin","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2826.2006.01508.x","article-title":"The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?","volume":"19","author":"Sherwin","year":"2007","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib77","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1471-4914(03)00117-5","article-title":"Disease model: Parkinson\u2019s disease","volume":"9","author":"Shimohama","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib78","series-title":"Annual Reports in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-7743(08)00002-X","article-title":"Chapter 2. Recent advances on the 5-HT5A, 5-HT6 and 5-HT7 receptors","author":"Shireman","year":"2008"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1550-8579(07)80003-9","article-title":"Gender differences in Parkinson\u2019s disease","volume":"4","author":"Shulman","year":"2007","journal-title":"Gend. Med."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib80","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2004.03.020","article-title":"5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta","volume":"491","author":"Siddiqui","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.58.6.529","article-title":"Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial","volume":"58","author":"Soares","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0173(01)00106-0","article-title":"An overview on functional receptor autoradiography using [35S]GTPgammaS","volume":"38","author":"Sovago","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bpobgyn.2008.11.001","article-title":"Are oestrogens useful for the treatment of depression in women?","volume":"23","author":"Studd","year":"2009","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-328X(99)00243-0","article-title":"Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement","volume":"73","author":"Sumner","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2008.05.031","article-title":"Perspectives on hormone replacement therapy: the Women\u2019s Health Initiative and new observational studies sampling the overall population","volume":"90","author":"Tannen","year":"2008","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib88","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.bjp.0701946","article-title":"Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719","volume":"124","author":"Thomas","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568007043482633","article-title":"5-HT7 receptors","volume":"3","author":"Thomas","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib90","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.54.12.2292","article-title":"Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations","volume":"54","author":"Tsang","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib91","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1176\/jnp.17.3.310","article-title":"Prevalence and treatment of depression in Parkinson\u2019s disease","volume":"17","author":"Veazey","year":"2005","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib92","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.psyneuen.2009.01.004","article-title":"Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance","volume":"34","author":"Walf","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2010.11.024_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00213-2","article-title":"Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor","volume":"396","author":"Wood","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.neuropharm.2010.11.024_bib94","first-page":"III5","article-title":"Depression in Parkinson\u2019s disease: its prevalence, diagnosis, and neurochemical background","volume":"248","author":"Yamamoto","year":"2001","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib95","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1016880127635","article-title":"The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review","volume":"12","author":"Zec","year":"2002","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neuropharm.2010.11.024_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.physbeh.2007.05.033","article-title":"Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson\u2019s disease model","volume":"92","author":"Zhang","year":"2007","journal-title":"Physiol. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810003230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810003230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:53:24Z","timestamp":1762214004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810003230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0028390810003230"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.11.024","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}